1,720,983 research outputs found

    MSJ901272_supplemental_tables – Supplemental material for Serum neurofilament light chain reflects inflammation-driven neurodegeneration and predicts delayed brain volume loss in early stage of multiple sclerosis

    No full text
    Supplemental material, MSJ901272_supplemental_tables for Serum neurofilament light chain reflects inflammation-driven neurodegeneration and predicts delayed brain volume loss in early stage of multiple sclerosis by Barbora Srpova, Tomas Uher, Tereza Hrnciarova, Christian Barro, Michaela Andelova, Zuzanna Michalak, Manuela Vaneckova, Jan Krasensky, Libuse Noskova, Eva Kubala Havrdova, Jens Kuhle and Dana Horakova in Multiple Sclerosis Journal</p

    MSJ901272_supplemental_figures – Supplemental material for Serum neurofilament light chain reflects inflammation-driven neurodegeneration and predicts delayed brain volume loss in early stage of multiple sclerosis

    No full text
    Supplemental material, MSJ901272_supplemental_figures for Serum neurofilament light chain reflects inflammation-driven neurodegeneration and predicts delayed brain volume loss in early stage of multiple sclerosis by Barbora Srpova, Tomas Uher, Tereza Hrnciarova, Christian Barro, Michaela Andelova, Zuzanna Michalak, Manuela Vaneckova, Jan Krasensky, Libuse Noskova, Eva Kubala Havrdova, Jens Kuhle and Dana Horakova in Multiple Sclerosis Journal</p

    sj-docx-1-msj-10.1177_13524585211047977 – Supplemental material for Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis

    No full text
    Supplemental material, sj-docx-1-msj-10.1177_13524585211047977 for Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis by Tomas Uher, Eva Kubala Havrdova, Pascal Benkert, Niels Bergsland, Jan Krasensky, Barbora Srpova, Michael Dwyer, Michaela Tyblova, Stephanie Meier, Manuela Vaneckova, Dana Horakova, Robert Zivadinov, David Leppert, Tomas Kalincik and Jens Kuhle in Multiple Sclerosis Journal</p

    sj-docx-2-msj-10.1177_13524585211047977 – Supplemental material for Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis

    No full text
    Supplemental material, sj-docx-2-msj-10.1177_13524585211047977 for Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis by Tomas Uher, Eva Kubala Havrdova, Pascal Benkert, Niels Bergsland, Jan Krasensky, Barbora Srpova, Michael Dwyer, Michaela Tyblova, Stephanie Meier, Manuela Vaneckova, Dana Horakova, Robert Zivadinov, David Leppert, Tomas Kalincik and Jens Kuhle in Multiple Sclerosis Journal</p

    sj-docx-3-msj-10.1177_13524585211047977 – Supplemental material for Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis

    No full text
    Supplemental material, sj-docx-3-msj-10.1177_13524585211047977 for Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis by Tomas Uher, Eva Kubala Havrdova, Pascal Benkert, Niels Bergsland, Jan Krasensky, Barbora Srpova, Michael Dwyer, Michaela Tyblova, Stephanie Meier, Manuela Vaneckova, Dana Horakova, Robert Zivadinov, David Leppert, Tomas Kalincik and Jens Kuhle in Multiple Sclerosis Journal</p

    sj-tiff-1-msj-10.1177_13524585211047977 – Supplemental material for Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis

    No full text
    Supplemental material, sj-tiff-1-msj-10.1177_13524585211047977 for Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis by Tomas Uher, Eva Kubala Havrdova, Pascal Benkert, Niels Bergsland, Jan Krasensky, Barbora Srpova, Michael Dwyer, Michaela Tyblova, Stephanie Meier, Manuela Vaneckova, Dana Horakova, Robert Zivadinov, David Leppert, Tomas Kalincik and Jens Kuhle in Multiple Sclerosis Journal</p

    MSJ912379_supplemental_appendix_2 – Supplemental material for Neurofilament levels are associated with blood–brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis

    No full text
    Supplemental material, MSJ912379_supplemental_appendix_2 for Neurofilament levels are associated with blood–brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis by Tomas Uher, Mason McComb, Shery Galkin, Barbora Srpova, Johanna Oechtering, Christian Barro, Michaela Tyblova, Niels Bergsland, Jan Krasensky, Michael Dwyer, Eva Kubala Havrdova, Helena Posova, Manuela Vaneckova, Robert Zivadinov, Dana Horakova, Jens Kuhle and Murali Ramanathan in Multiple Sclerosis Journal</p

    MSJ912379_supplemental_appendix_1 – Supplemental material for Neurofilament levels are associated with blood–brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis

    No full text
    Supplemental material, MSJ912379_supplemental_appendix_1 for Neurofilament levels are associated with blood–brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis by Tomas Uher, Mason McComb, Shery Galkin, Barbora Srpova, Johanna Oechtering, Christian Barro, Michaela Tyblova, Niels Bergsland, Jan Krasensky, Michael Dwyer, Eva Kubala Havrdova, Helena Posova, Manuela Vaneckova, Robert Zivadinov, Dana Horakova, Jens Kuhle and Murali Ramanathan in Multiple Sclerosis Journal</p

    sj-docx-1-tan-10.1177_17562864231221331 – Supplemental material for Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies

    No full text
    Supplemental material, sj-docx-1-tan-10.1177_17562864231221331 for Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies by Helmut Butzkueven, Tomas Kalincik, Francesco Patti, Mark Slee, Bianca Weinstock-Guttman, Katherine Buzzard, Olga Skibina, Raed Alroughani, Alexandre Prat, Marc Girard, Dana Horakova, Eva Kubala Havrdova, Anneke Van der Walt, Sara Eichau, Robert Hyde, Nolan Campbell, Karthik Bodhinathan and Tim Spelman in Therapeutic Advances in Neurological Disorders</p

    MSJ912379_supplemental_tables – Supplemental material for Neurofilament levels are associated with blood–brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis

    No full text
    Supplemental material, MSJ912379_supplemental_tables for Neurofilament levels are associated with blood–brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis by Tomas Uher, Mason McComb, Shery Galkin, Barbora Srpova, Johanna Oechtering, Christian Barro, Michaela Tyblova, Niels Bergsland, Jan Krasensky, Michael Dwyer, Eva Kubala Havrdova, Helena Posova, Manuela Vaneckova, Robert Zivadinov, Dana Horakova, Jens Kuhle and Murali Ramanathan in Multiple Sclerosis Journal</p
    corecore